Skip to main navigation Skip to search Skip to main content

EnsembleAge clock: a reliable and robust epigenetic age clock service reveals epigenetic age acceleration in opioid-overdosed brains

  • Akshay Anand
  • , Yash Agarwal
  • , Tanisha Gupta
  • , Jason Lin
  • , Mirna Ghemrawi
  • , Glenn S. Gerhard
  • , Hayan Lee
  • Fox Chase Cancer Center
  • University of California Berkeley
  • University of California
  • College of Computing
  • Brown University
  • Florida International University
  • Temple University

Research output: Contribution to journalArticlepeer-review

Abstract

Age is a major risk factor for various diseases, such as cancer, cardiovascular conditions, and neurodegenerative diseases. However, chronological age, the simple number of years one has lived, does not capture individual health differences, prompting the development of methods to accurately estimate biological age instead of relying on chronological age. One of the major molecular approaches exploits DNA methylation (DNAm), which is an essential epigenetic modifier for regulating gene expression, cell differentiation, and aging. DNAm-based aging clocks have been developed to predict biological age, but the prediction is highly dependent on training data, including organs and assay technologies. To address these clocks’ high variance, we present two EnsembleAge clocks, leveraging eight previously developed DNAm clocks, harnessing the strengths of each methylome age clock, smoothing out individual variances, and providing a more robust estimation of biological age. We trained our EnsembleAge clock models using DNA methylation data from nine organs in the Genotype-Tissue Expression (GTEx) dataset. Our EnsembleNaive clock model achieved the lowest median absolute error (MeAE) of 4.04 years in whole blood. The EnsembleLR model demonstrated the lowest MeAE of 6.35 years across multiple tissues, including breast, lung, muscle, ovary, prostate, testis, and colon. The significant reduction in MeAE underscores its high practical value in clinical and forensic applications, especially in contexts where epigenetic changes are subtle. We further applied our models to four public datasets representing diverse biological applications, including administered short-term medical opioid use (GSE151485) and long-term opioid overdose (GSE164822). Our model reveals over 10 years of age acceleration in opioid-overdosed brains but no significant epigenetic age acceleration when opioid usage was well administered. Our EnsembleAge clock models are also implemented as a web service, allowing users to conveniently upload their DNA methylation data and receive predictions of their biological age. This empowers individuals to track their biological/epigenetic age over time, mitigating the effect of variance and promoting healthy aging and a beneficial lifestyle. Our EnsembleAge clock service is available at https://ensemble.epiclock.app/.

Original languageEnglish
Article number1088
Pages (from-to)1088
JournalBmc Genomics
Volume26
Issue number1
DOIs
StatePublished - Dec 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Aging biomarker
  • DNA methylation
  • Epigenetic age clock
  • Machine learning

Fingerprint

Dive into the research topics of 'EnsembleAge clock: a reliable and robust epigenetic age clock service reveals epigenetic age acceleration in opioid-overdosed brains'. Together they form a unique fingerprint.

Cite this